U.S. Packaging Stock News

Boise Cascade recently completed its acquisition of Massachusetts-based distributor Holden Humphrey, while also announcing that CEO Nate Jorgensen will retire in March 2026 with COO Jeff Strom set to succeed him as part of a planned leadership transition. These operational and leadership moves, alongside renewed confidence from Wall Street analysts, highlight how Boise Cascade is reshaping its footprint and governance for longer-term positioning. Next, we’ll explore how the Holden Humphrey...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Mesa Laboratories, Inc. ( NASDAQ:MLAB ) will pay a dividend of $0.16 on the 16th of March. The dividend yield will be...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Crane (NYSE:CR) has had a great run on the share market with its stock up by a significant 13% over the last three...

The board of Jefferies Financial Group Inc. ( NYSE:JEF ) has announced that it will pay a dividend on the 27th of...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Despite an already strong run, Hawaiian Electric Industries, Inc. ( NYSE:HE ) shares have been powering on, with a gain...

NCR Voyix recently unveiled a next-generation portfolio of cloud-native, microservices-based applications on its Voyix Commerce Platform, aimed at modernizing retail and restaurant operations across point-of-sale, self-checkout, back office, supply chain, kitchens, analytics and loyalty. A distinctive element of this launch is the tight integration of AI-driven tools, such as computer vision Picklist Assist and conversational analytics, which are intended to accelerate software development,...

In January 2026, HNI Corporation announced plans to exit its Wayland, New York manufacturing facility by 2027, consolidating production into other North American plants, which will affect about 135 employees and is expected to generate US$7.5–US$8.0 million in annual cost savings once fully implemented, alongside roughly US$14.9 million in pre-tax charges across 2026 and 2027. This move is linked to the integration of Kimball International, with total expected cost synergies now projected to...

Maase Inc. (MAAS) in focus after recent price swing Maase (NasdaqGM:MAAS), a Chengdu based financial technology and wealth management company, has drawn fresh attention after a recent share price move, prompting investors to reassess how its China focused model fits their portfolios. See our latest analysis for Maase. Recent trading has been choppy, with a 30 day share price return of 34.26% and a 90 day share price return of 74.75%. This contrasts with a year to date share price return of an...

In December 2025, Breggz announced that its Zohn-1 wireless in-ear hearables became the first earphones to earn IMAX® Enhanced certification, extending IMAX’s immersive standards to a new personal audio category alongside existing TVs, laptops, tablets, phones, AVRs, speakers, and soundbars. This move into certified in-ear hearables highlights how IMAX is pushing its technology beyond cinema screens, deepening its role in how fans experience premium content across devices. We’ll now examine...

MoonLake Immunotherapeutics recently reported that the U.S. FDA, following a Type B meeting, indicated its existing MIRA, VELA-1 and VELA-2 trial data for sonelokimab in hidradenitis suppurativa may be sufficient to support a Biologics License Application, which the company plans to submit in the second half of 2026. An interesting aspect of the FDA feedback is that MoonLake may establish substantial evidence of effectiveness without running additional HS trials, potentially simplifying and...

CNO Financial Group (CNO) shares recently reached an all time high of US$44.06 after third quarter earnings and revenue came in ahead of analyst expectations, followed by an upgrade from Jefferies. See our latest analysis for CNO Financial Group. The latest all time high sits against a solid backdrop, with CNO Financial Group’s 90 day share price return of 10.15% and 1 year total shareholder return of 22.67% pointing to building momentum rather than a short lived spike. If CNO’s move has...

Insider sale and fresh coverage put Peoples Bancorp (PEBO) on investors' radar A recent Buy initiation from DA Davidson and a 1,000 share sale by director Carol A. Schneeberger under a Rule 10b5-1 plan have brought fresh attention to Peoples Bancorp (PEBO). See our latest analysis for Peoples Bancorp. At a share price of US$30.83, Peoples Bancorp has seen mixed short term moves, with a 1 day share price return of 1.44% decline but a 90 day share price return of 5.76%. The 3 year total...

Recent coverage highlighted that First BanCorp’s differentiated product suite, strong loan book performance, and net interest margin of 4.5% have helped underpin earnings power and capital strength in the period leading up to today. An interesting angle is how substantial share buybacks have amplified annual earnings per share growth to very large levels and driven tangible book value per share higher, reinforcing the impact of management’s capital allocation approach. With this context,...

PACS Group (PACS) is back in focus after recent leadership appointments, improved internal controls following an audit, and renewed analyst confidence. Together, these developments are shaping fresh investor interest in the stock. See our latest analysis for PACS Group. Those leadership and governance updates have arrived while the stock has been on a strong run, with a 30 day share price return of 18.63% and a 90 day share price return of 232.82%, contributing to a 1 year total shareholder...

Molson Coors Beverage (TAP) is back in focus as investors weigh ongoing volume declines, pressured margins, and a negative return on capital against upcoming management commentary at February’s CAGNY conference and the 2025 earnings release. See our latest analysis for Molson Coors Beverage. At a share price of US$48.13, Molson Coors has seen a 4.56% 90 day share price return. However, its 1 year total shareholder return of a 4.8% decline suggests fading momentum despite upcoming earnings and...

Goal Investment Management recently announced it has formed a joint venture with Ares Alternative Credit funds to acquire and manage consumer loan portfolios across areas such as education finance, home improvement, solar, and installment lending. This partnership, combined with rising expectations ahead of Ares Management’s upcoming fourth-quarter 2025 earnings release, highlights how the firm is broadening its alternative credit reach and potential fee sources. We’ll now examine how the...

Oshkosh (OSK) is back in the spotlight after multiple CES Picks and Innovation Awards highlighted its AI driven and autonomous safety technologies, including the Collision Avoidance Mitigation System for emergency responders. See our latest analysis for Oshkosh. Those CES awards arrive at a time when momentum in Oshkosh’s shares is strong, with a 13.8% 7 day share price return and a 70.99% 1 year total shareholder return, suggesting growing investor interest in its technology story. If...

If you are wondering whether Victoria's Secret stock still offers value after its recent run, this article will walk through what the current price might be telling you. The shares last closed at US$65.90, with returns of 23.5% over the past week, 20.9% over the last 30 days, 23.5% year to date, 75.4% over 1 year, and 71.7% over 3 years. Recent coverage has focused on Victoria's Secret as a standalone brand and retailer. Investors are paying close attention to how it is repositioning itself...

Earlier this month, DISCO Pharmaceuticals announced an exclusive license agreement granting Amgen global rights to develop and commercialize cancer therapies from DISCO’s cell-surface proteomics platform, with DISCO eligible for up to US$618 million in total deal value plus royalties. This partnership adds another specialized oncology program to Amgen’s pipeline at the same time that investors are closely watching its late-stage obesity and cardiovascular candidates. We’ll now examine how...

Brookfield Infrastructure stock snapshot Brookfield Infrastructure (BIPC) shares have retreated over the past month and past 3 months, with the stock closing at US$43.26. This may prompt investors to reassess the company’s current valuation and fundamentals. See our latest analysis for Brookfield Infrastructure. BIPC’s recent 1 month share price return of a 6.63% decline and 3 month share price return of a 5.07% decline contrast with a 1 year total shareholder return of 18.58%, suggesting...